Skip to main navigation Skip to search Skip to main content

A phase I/II study of pembrolizumab (P) with gemcitabine (G) in patients (Pts) with previously-treated advanced non-small cell lung cancer (NSCLC): Phase I safety results.

  • Rachel E. Sanborn
  • , Regan M. Duffy
  • , Brenda K Fisher
  • , Kelly Shea Perlewitz
  • , William L Redmond
  • , Yoshinobu Koguchi
  • , Bernard A. Fox

    Research output: Contribution to journal › Article › peer-review

    Original languageAmerican English
    JournalJournal of Clinical Oncology
    Volume35
    DOIs
    StatePublished - May 20 2017

    Disciplines

    • Pathology
    • Internal Medicine
    • Medicine and Health Sciences
    • Immunology and Infectious Disease
    • Oncology

    Cite this